$Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy$

Long-term remission in a child with refractory EBV+ hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV+ -related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy

Afficher d'autres versions (1)

Détails bibliographiques
Auteurs principaux:	El-Mallawany, N, Geller, L, Bollard, C, Wistinghausen, B, Mussai, F, Wayne, A, Alobeid, B, Cairo, MS
Format:	Journal article
Langue:	English
Publié:	2011

Documents similaires

Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy.
par: El-Mallawany, N, et autres
Publié: (2011)

Extensive hydroa vacciniforme
par: Hiram Larangeira de Almeida Jr, et autres
Publié: (2013-08-01)

Hydroa vacciniforme-like lymphoma
par: Zhang Fang, et autres
Publié: (2019-01-01)

Hydroa vacciniforme-like cutaneous T-cell lymphoma
par: Jian-Qiang Shi, et autres
Publié: (2014-01-01)

Hydroa vacciniforme lymphoproliferative disorder：a case report
par: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Publié: (2023-12-01)

Hydroa vacciniforme on a dark skin with mucosal involvement
par: Kelati Awatef, et autres
Publié: (2016-03-01)

EBV & lymphoma
par: Dolores Caballero, (Coordinating Author)
Publié: (2019-06-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
par: Yi Tian Png, et autres
Publié: (2021-02-01)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
par: Qiuting Zhang, et autres
Publié: (2023-09-01)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
par: Mikhail Y. Salnikov, et autres
Publié: (2023-03-01)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
par: Ting Liu, et autres
Publié: (2023-06-01)

Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children
par: Agata Marjańska, et autres
Publié: (2024-07-01)

EBV CHRONIC INFECTIONS
par: Delia Racciatti, et autres
Publié: (2010-02-01)

EBV IN HODGKIN LYMPHOMA
par: Giuseppina Massini, et autres
Publié: (2009-11-01)

EBV CHRONIC INFECTIONS
par: Eligio Pizzigallo, et autres
Publié: (2010-08-01)

EBV IN HODGKIN LYMPHOMA
par: Stefan Hohaus, et autres
Publié: (2009-11-01)

Progress in EBV Vaccines
par: Dwain G. van Zyl, et autres
Publié: (2019-02-01)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
par: Darja Kanduc, et autres
Publié: (2020-08-01)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
par: Andrea Alberti, et autres
Publié: (2023-10-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
par: James P. Dugan, et autres
Publié: (2019-03-01)

Hydroa vacciniforme in an adult male albino: A rare case report
par: Sunil Kumar Gupta, et autres
Publié: (2024-05-01)

Hydroa vacciniforme-like lymphoma with systemic symptoms: Two case reports
par: Litao Wang, et autres
Publié: (2019-01-01)

Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells.
par: J Luis Espinoza, et autres
Publié: (2012-01-01)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
par: Thomas Mika, et autres
Publié: (2019-12-01)

EBV AND HIV-RELATED LYMPHOMA
par: Michele Bibas, et autres
Publié: (2009-12-01)

EBV AND HIV-RELATED LYMPHOMA
par: Andrea Antinori, et autres
Publié: (2009-11-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
par: ستار عبود فارس, et autres
Publié: (2019-05-01)

??????? ??? ????? ????? ???????- ???Epstein-Barr virus(EBV) ????? ?????? ????? ????? ?? ?????? ?? ???
par: ستار عبود فارس, et autres
Publié: (2019-05-01)

Roles of EBV in Haemopoetic Malignancies
par: Takahara Miki, et autres
Publié: (2005-12-01)

Syntropy in Children with EBV Infection
par: L.A. Khodak, et autres
Publié: (2015-05-01)

EBV-associated lymphoadenopathy in a child
par: H.B. Mateiko, et autres
Publié: (2024-12-01)

EBV-requisitioning physicians’ guess on fatigue state 6 months after acute EBV infection
par: Tarjei Tørre Asprusten, et autres
Publié: (2019-09-01)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
par: Marija Rozman, et autres
Publié: (2022-07-01)

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
par: Qinyan Yin, et autres
Publié: (2017-06-01)

HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
par: Midan Ai, et autres
Publié: (2008-09-01)

The EBV-MS connection: the enigma remains
par: A. van de Waterweg Berends, et autres
Publié: (2024-08-01)

EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes
par: Nancy Law, et autres
Publié: (2024-08-01)

Refractory Hydroa Vacciniforme-Like Lymphoma: Biological Insights from Morphoproteomic Analysis
par: Rohit Goswamy, et autres
Publié: (2022-07-01)

Adult-onset hydroa vacciniforme: A rare occurrence or a lymphoma premonition?
par: Ankita Sangwan, et autres
Publié: (2017-01-01)

Regulation mechanism of EBV-encoded EBER1 and LMP2A on YAP1 and the impact of YAP1 on the EBV infection status in EBV-associated gastric carcinoma
par: Yujie Sun, et autres
Publié: (2024-05-01)